<- Go Home
Neovasc Inc.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
Market Cap
CAD 82.6M
Volume
962.00
Cash and Equivalents
CAD 25.8M
EBITDA
-CAD 37.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-CAD 1.3M
Profit Margin
33.37%
52 Week High
CAD 30.46
52 Week Low
CAD 4.44
Dividend
N/A
Price / Book Value
5.16
Price / Earnings
-1.97
Price / Tangible Book Value
5.16
Enterprise Value
CAD 69.8M
Enterprise Value / EBITDA
-1.86
Operating Income
-CAD 37.9M
Return on Equity
121.07%
Return on Assets
-43.32
Cash and Short Term Investments
CAD 25.8M
Debt
CAD 13.0M
Equity
CAD 15.8M
Revenue
CAD 3.8M
Unlevered FCF
-CAD 10.6M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium